Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.
This study is not yet recruiting. It focuses on depression and currently lists study information in France.
In France
This study is not yet recruiting. It focuses on schizophrenia and currently lists study information in France.
In FranceThis study is not yet recruiting. It focuses on schizophrenia and currently lists study information in Chile, France, Germany, Poland, and Spain.
In FranceThis study is not yet recruiting. It focuses on schizophrenia and currently lists study information in France.
In France
This study is not yet recruiting. It focuses on ADHD and currently lists study information in France.
In FranceThis study is not yet recruiting. It focuses on depression and currently lists study information in France.
Remote / onlineThis study is not yet recruiting. It focuses on schizophrenia and currently lists study information in France.
In FranceThis study is not yet recruiting. It focuses on schizophrenia and currently lists study information in France.
Broader result
This study has public registry information. It focuses on schizophrenia and currently lists study information in Austria, Belgium, France, Germany, Poland, the United States, Romania, Spain, and Sweden.
In FranceThis study has public registry information. It focuses on schizophrenia and currently lists study information in France.
Remote / onlineThis study is ongoing in France, in the United Kingdom, in Czech Republic, .... It is testing pimavanserin for Schizophrenia.
In FranceThis study is completed. It focuses on ADHD and currently lists study information in Austria, Belgium, Finland, France, Germany, Italy, the Netherlands, Portugal, Spain, Sweden, Switzerland, and the United Kingdom.
In France